Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

Eli Lilly stocks down, Novo Nordisk stocks up after REWIND data goes public

Eli Lilly stocks are down 1.4% in premarket trading this week after the company announced the results of its long-awaited REWIND study, Barron’s reported.

Thumbnail

ACC, Veradigm partner to create largest ambulatory chronic disease network in the US

The American College of Cardiology is partnering with Chicago-based company Veradigm to assemble the largest-ever ambulatory chronic disease network in the U.S., comprising more than 250,000 clinicians and 100 million patients.

Thumbnail

Louisville to become a hub for AI in healthcare with Microsoft support

Microsoft is launching a regional hub for AI, Internet of Things and data science in Louisville, Kentucky, according to Mayor Greg Fischer, with a focus on collaborating with partners in healthcare and manufacturing.

Thumbnail

Strategic Radiology adds North Carolina’s oldest radiology practice

Strategic Radiology announced Tuesday, June 11, that Charlotte, North Carolina-based Mecklenburg Radiology Associates (MRA) has joined its growing coalition of independent practices.

Thumbnail

Radiologist found negligent in $11.5M medical malpractice suit

A jury has awarded a young patient $11.5 million in a medical malpractice lawsuit filed against a radiologist at Boston’s Newton-Wellesley Hospital. 

Thumbnail

Massachusetts patient awarded $11.5M in radiology malpractice suit

A jury awarded $11.5 million to a woman from Framingham, Massachusetts, in a medical malpractice suit filed against a radiologist in the state, which argued he was negligent in not adequately identifying a heart problem that eventually led to permanent brain damage, according to the Boston Globe.

Thumbnail

ASTRO voices support for new prior authorization legislation

The American Society for Radiation Oncology (ASTRO) is championing bipartisan legislation introduced Wednesday, June 5, that would reduce prior authorization practices found to delay patient access to necessary cancer treatments.

Thumbnail

Latest analysis of evolocumab suggests the drug is—finally—affordable

An updated cost-effectiveness analysis of evolocumab suggests that while treatment with the PCSK9 inhibitor may always be somewhat costly, it remains effective in hard-to-treat patients and its reduced list price meets cost-effectiveness thresholds across a range of CV events in patients with very-high-risk atherosclerotic CVD.